Table 2 Prevalence of oral mucosal lesions in the total group of skin diseased patients (n = 544), in the group of skin diseased patients with OML and within the 14 most frequently occurring OML groups

Tongue lesions

n (%)

%

%

Coated tongue

61 (11.2)

19.4

48.0

Fissured tongue

26 (4.8)

8.3

20.5

Geographic tongue

23 (4.2)

7.3

18.1

2(+ve)*

Atrophy of tongue papillae

17 (3.1)

5.4

13.4

1(+ve)

Geographic tongue+Fissured tongue

12 (2.2)

3.8

9.4

Tongue-tie

4 (0.7)

1.3

3.1

Total number of patients with any tongue lesion ¶

127 (23.3)

40.3

White lesions

Snuff dipper's lesion

30 (5.5)

9.5

28.8

8(+ve)

Frictional lesions

25 (4.6)

7.9

24.0

4(+ve)

Leukoplakia

17 (3.1)

5.4

16.3

5(+ve)

Vitiligo

16 (2.9)

5.1

15.4

Nicotine stomatitis

7 (1.3)

2.2

6.7

Lichen planus

5 (0.9)

1.6

4.8

3(+ve)

Lupus erythematosus

4 (0.7)

1.3

3.8

1(-ve)§

Unspecified nicotine stomatitis

3 (0.6)

1.0

2.9

Lichenoid lesions

1 (0.2)

0.3

1.0

1(+ve)

Total number of patients with any white lesion ¶

104 (19.1)

33.0

Red and blue lesions

Erythema

29 (5.3)

9.2

48.3

2(-ve)

Petechia

25 (4.6)

7.9

41.7

Erosion

7 (1.3)

2.2

11.7

Hemangioma

3 (0.6)

1.0

5.0

Total number of patients with any red and blue lesion ¶

60 (11)

19.0

100

Vesiculobullous diseases

Pemphigus vulgaris

15(2.8)

4.8

46.9

9(8+ve)

Chickenpox

8(1.5)

2.5

25

Bullous pemphigoid

6(1.1)

1.9

18.7

3(-ve)

Herpes labialis

2(0.4)

0.6

6.2

Vesiculobullous lesion (not verified)

1(0.2)

0.3

3.1

Total number of patients with any vesiculobullous disease

32 (6)

10.2

100

Ulcerative conditions

RAS

16 (2.9)

5.1

66.7

1(+ve)

Drug reaction

3 (0.6)

1.0

12.5

Stevens-Johonson syndrome

2 (0.4)

0.6

8.3

Erythema multiforme

1 (0.2)

0.3

4.2

Traumatic ulcer

1 (0.2)

0.3

4.2

Unspecified ulcer

1 (0.2)

0.3

4.2

Total number of patients with any ulcerative condition

24 (4.5)

7.6

100

Pigmented Lesions

Melanotic macules

20 (3.7)

6.3

95

1(+ve)

Gingival tattoo

1 (0.2)

0.3

4.8

Total number of patients with any pigmented Lesion

21 (3.9)

6.7

100

Connective tissue lesions

Fibroepithelial polyp

9 (1.7)

2.9

81.8

4(+ve)

Denture induced fibrous hyperplasia

2 (0.4)

0.6

18.2

Total number of patients with any connective tissue lesion

11 (2.1)

3.5

100

Fungal infections

Acute erythematous candidiasis

3 (0.6)

1.0

30

1(-ve)

Median rhomboid glossitis

3 (0.6)

1.0

30

Pseodomembranous candidiasis

3 (0.6)

1.0

30

Angular cheilitis

2 (0.4)

0.6

20

Chronic hyperplastic candidiasis

1 (0.2)

0.3

10

Total number of patients with any fungal infection ¶

10 (1.8)

3.2

100

Benign nonodontogenic tumors

Soft tumor like lesion

4 (0.7)

1.3

66.7

1(-ve)

Exostosis

1 (0.2)

0.3

16.7

Palatal tori

1 (0.2)

0.3

16.7

Total number of patients with any benign nonodontogenic tumor

6 (11)

1.9

100

Perioral lesions

Perioral dermatitis

4 (0.7)

1.3

80

Perioral wart

1 (0.2)

0.3

20

Total number of patients with any perioral lesion

5 (0.9)

1.6

100

Lip lesions

Unspecified cheilitis

2 (0.4)

0.6

40

Hypopigmented lips

2 (0.4)

0.6

40

Cheilitis glandularis

1 (0.2)

0.3

20

Total number of patients with any lip lesion

5 (1.0)

1.6

100

Verrucal papillary lesions

Papillary hyperplasia

3 (0.6)

1.0

75

1(+ve)

Focal epithelial hyperplasia

1 (0.2)

0.3

25

Total number of patients with any verrucal papillary lesion

4 (0.7)

1.3

100

Salivary gland diseases

Mucocele

2 (0.4)

0.6

100

2(+ve)

Total number of patients with any salivary gland disease

2

Malignant tumours

Kaposi sarcoma

1 (0.2)

0.3

100

Total number of patients with any malignant tumour

1